Detailed information for compound 1720457

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 1073.1 | Formula: C58H58F2N4O14
  • H donors: 6 H acceptors: 8 LogP: 8.55 Rotable bonds: 26
    Rule of 5 violations (Lipinski): 3
  • SMILES: COc1cc(ccc1OCc1ccc(cc1)F)[C@@H]1[C@@](NC(=O)c2ccc(cc2)NC(=O)OC(C)(C)C)(C(=O)O)[C@@H]([C@@]1(NC(=O)c1ccc(cc1)NC(=O)OC(C)(C)C)C(=O)O)c1ccc(c(c1)OC)OCc1ccc(cc1)F
  • InChi: 1S/C58H58F2N4O14/c1-55(2,3)77-53(71)61-41-23-13-35(14-24-41)49(65)63-57(51(67)68)47(37-17-27-43(45(29-37)73-7)75-31-33-9-19-39(59)20-10-33)58(52(69)70,64-50(66)36-15-25-42(26-16-36)62-54(72)78-56(4,5)6)48(57)38-18-28-44(46(30-38)74-8)76-32-34-11-21-40(60)22-12-34/h9-30,47-48H,31-32H2,1-8H3,(H,61,71)(H,62,72)(H,63,65)(H,64,66)(H,67,68)(H,69,70)/t47-,48+,57+,58-
  • InChiKey: XDIQZEZDSPULJB-UYLASBEKSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma brucei branched-chain amino acid aminotransferase, putative 0.1933 0.5 0.5
Mycobacterium ulcerans branched-chain amino acid aminotransferase 0.1933 0.5 0.5
Mycobacterium tuberculosis Branched-chain amino acid transaminase IlvE 0.1933 0.5 0.5
Trypanosoma brucei branched-chain amino acid aminotransferase, putative 0.1933 0.5 0.5
Loa Loa (eye worm) branched-chain amino acid aminotransferase 0.1933 0.5 0.5
Giardia lamblia Branched-chain amino acid aminotransferase lateral transfer candidate 0.1933 0.5 0.5
Leishmania major branched-chain amino acid aminotransferase, putative 0.1933 0.5 0.5
Trichomonas vaginalis branched-chain amino acid aminotransferase, putative 0.1933 0.5 0.5
Entamoeba histolytica branched-chain amino acid aminotransferase, putative 0.1933 0.5 0.5
Toxoplasma gondii Branched-chain-amino-acid aminotransferase 0.1933 0.5 0.5
Mycobacterium leprae PROBABLE BRANCHED-CHAIN AMINO ACID TRANSAMINASE ILVE 0.1933 0.5 0.5
Trypanosoma brucei branched-chain amino acid aminotransferase, putative 0.1933 0.5 0.5
Trichomonas vaginalis subgroup IIIi aminotransferase, putative 0.1933 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) > 20 uM Agonist activity at rat GLP1R expressed in HEK293 cells assessed as stimulation of cAMP levels incubated for 6 hrs by multiple response element/cAMP response element (MRE/CRE)-driven reporter gene assay ChEMBL. 22103243
Efficacy (functional) < 15 % Agonist activity at rat GLP1R expressed in HEK293 cells assessed as stimulation of cAMP levels incubated for 6 hrs by multiple response element/cAMP response element (MRE/CRE)-driven reporter gene assay relative to 10 nM GLP1 ChEMBL. 22103243
IC50 (binding) > 20 uM Inhibition of [125I]GLP1 (7-36) amide binding to rat GLP1R expressed in HEK293 cells ChEMBL. 22103243
Inhibition (binding) < 15 % Inhibition of [125I]Exendin (9-39) binding to rat GLP1R expressed in HEK293 cells ChEMBL. 22103243
Inhibition (binding) < 15 % Inhibition of [125I]GLP1 (7-36) amide binding to rat GLP1R expressed in HEK293 cells relative to untreated control ChEMBL. 22103243

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.